VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism
- PMID: 12087404
- DOI: 10.1038/nature00821
VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism
Abstract
Vascular endothelial growth factor (VEGF) is a principal regulator of blood vessel formation and haematopoiesis, but the mechanisms by which VEGF differentially regulates these processes have been elusive. Here we describe a regulatory loop by which VEGF controls survival of haematopoietic stem cells (HSCs). We observed a reduction in survival, colony formation and in vivo repopulation rates of HSCs after ablation of the VEGF gene in mice. Intracellularly acting small-molecule inhibitors of VEGF receptor (VEGFR) tyrosine kinase dramatically reduced colony formation of HSCs, thus mimicking deletion of the VEGF gene. However, blocking VEGF by administering a soluble VEGFR-1, which acts extracellularly, induced only minor effects. These findings support the involvement in HSC survival of a VEGF-dependent internal autocrine loop mechanism (that is, the mechanism is resistant to inhibitors that fail to penetrate the intracellular compartment). Not only ligands selective for VEGF and VEGFR-2 but also VEGFR-1 agonists rescued survival and repopulation of VEGF-deficient HSCs, revealing a function for VEGFR-1 signalling during haematopoiesis.
Similar articles
-
Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.Cancer Res. 2001 Oct 1;61(19):7002-8. Cancer Res. 2001. PMID: 11585724
-
Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.Cancer. 2000 Aug 1;89(3):488-99. Cancer. 2000. PMID: 10931447
-
Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.J Pharmacol Exp Ther. 2001 Dec;299(3):1073-85. J Pharmacol Exp Ther. 2001. PMID: 11714897
-
VEGF receptor signaling and endothelial function.IUBMB Life. 2001 Jul;52(1-2):61-6. doi: 10.1080/15216540252774784. IUBMB Life. 2001. PMID: 11795595 Review.
-
The biology of VEGF and its receptors.Nat Med. 2003 Jun;9(6):669-76. doi: 10.1038/nm0603-669. Nat Med. 2003. PMID: 12778165 Review.
Cited by
-
Regulation of Bone Marrow Angiogenesis by Osteoblasts during Bone Development and Homeostasis.Front Endocrinol (Lausanne). 2013 Jul 10;4:85. doi: 10.3389/fendo.2013.00085. eCollection 2013. Front Endocrinol (Lausanne). 2013. PMID: 23847596 Free PMC article.
-
The aryl hydrocarbon receptor nuclear translocator is an essential regulator of murine hematopoietic stem cell viability.Blood. 2015 May 21;125(21):3263-72. doi: 10.1182/blood-2014-10-607267. Epub 2015 Apr 8. Blood. 2015. PMID: 25855602 Free PMC article.
-
Autocrine VEGF maintains endothelial survival through regulation of metabolism and autophagy.J Cell Sci. 2015 Jun 15;128(12):2236-48. doi: 10.1242/jcs.163774. Epub 2015 May 8. J Cell Sci. 2015. PMID: 25956888 Free PMC article.
-
A method for rapid and reliable quantification of VEGF-cell binding activity.Biochem Biophys Res Commun. 2024 Oct 1;727:150321. doi: 10.1016/j.bbrc.2024.150321. Epub 2024 Jun 27. Biochem Biophys Res Commun. 2024. PMID: 38954982
-
Thirty years of intracrinology.Ochsner J. 2014 Winter;14(4):673-80. Ochsner J. 2014. PMID: 25598734 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
